FDA Approved: NILOTINIB — Original Application (Dr. Reddy's Laboratories Inc)

View source ↗

Summary

FDA approved Dr. Reddy's Laboratories' generic nilotinib under an Original Application (ANDA). It is indicated for chronic myeloid leukemia and Philadelphia chr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

ORIG AP for NILOTINIB (NILOTINIB)